首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Atherosclerosis

缩写:ATHEROSCLEROSIS

ISSN:0021-9150

e-ISSN:1879-1484

IF/分区:7.1/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引8240条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Xiaoyong Hu,Hongjian Li,Zhaoying Yang et al. Xiaoyong Hu et al.
Background and aims: Vascular injury triggers perivascular adipose tissue (PVAT) browning, an adaptive response critical for vascular protection, yet its regulatory mechanisms remain unclear. This study aimed to identify ...
Yara Azar,Yara Abou Khalil,Marie-Nathalie Lebel et al. Yara Azar et al.
Aims: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is the third gene involved in autosomal dominant hypercholesterolemia, an atherosclerosis major cause. Its role in regulating plasma cholesterol through hepatocy...
Zijia Liu,Fengjun Du,Chunhua Zhao et al. Zijia Liu et al.
Background and aims: Breast cancer (BC) and cardiovascular disease (CVD) are leading causes of death in women. However, their bidirectional relationship and key risk factors remain unclear. ...
Trina Roy,Aleepta Guha Ray,Subhamoy Pratihar et al. Trina Roy et al.
Background and aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with accelerated atherosclerosis and cardiovascular complications, yet the hepatic redox-dependent mechanisms lin...
Wenzhuo Meng,Cong Wang,Zeqin Xu et al. Wenzhuo Meng et al.
Background and aims: Remnant cholesterol (RC) has emerged as an atherogenic lipid fraction that may be associated with residual cardiovascular risk beyond low density lipoprotein cholesterol (LDL-C). However, its role in ...
Vishnu Goutham Kota,Jordan Low Jun Yi,Zhiyi Zhang et al. Vishnu Goutham Kota et al.
Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), are the leading chronic liver diseases globally and are closely linked to systemic metabolic...